Trimethoprim-sulphamethoxazole problems in treating lower respiratory tract infections.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole